New heart valve implant trial aims to stop dangerous leaks
NCT ID NCT07454980
Summary
This trial is testing a new device called the LuX-Valve Plus system to treat a severe leak in the heart's tricuspid valve. It will compare the new device to an existing one (EVOQUE) in 680 patients who have symptoms like shortness of breath and fatigue. The main goals are to see if the new device is safe and effective at controlling the leak and preventing serious heart problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRICUSPID REGURGITATION (TR) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.